ライフサイエンスコーパス: dengue hemorrhagic fever

1 are the causative agents of dengue fever and dengue hemorrhagic fever.

2 g a marked reduction in platelet counts, and dengue hemorrhagic fever.

3 ated in the majority of severe cases, termed dengue hemorrhagic fever.

4 significantly with the demographic burden of dengue hemorrhagic fever.

5 time of viral clearance and defervescence in dengue hemorrhagic fever.

6 World Health Organization classification of dengue hemorrhagic fever.

7 in HIV infection and with protection against dengue hemorrhagic fever.

8 roposed as a mechanism for plasma leakage in dengue hemorrhagic fever.

9 us (DV) infections are at increased risk for dengue hemorrhagic fever.

10 e and cause dengue fever and the more severe dengue hemorrhagic fever.

11 laviviruses responsible for dengue fever and dengue hemorrhagic fever.

12 ought to be important in the pathogenesis of dengue hemorrhagic fever.

13 isk for the more severe form of the disease, dengue hemorrhagic fever.

14 fection as well as the immunopathogenesis of dengue hemorrhagic fever.

15 striking in vivo example of ADE in humans is dengue hemorrhagic fever, a disease in which ADE is thou

16 h symptomatic dengue, including 205 cases of dengue hemorrhagic fever and 12 deaths, were adults born

17 ter risk of severe dengue disease, including dengue hemorrhagic fever and dengue shock syndrome.

18 nfection ranges from inapparent infection to dengue hemorrhagic fever and dengue shock syndrome.

19 ially fatal severe dengue disease, including dengue hemorrhagic fever and dengue shock syndrome.

20 ge of the vascular endothelium, resulting in dengue hemorrhagic fever and dengue shock syndrome.

21 the pathophysiologic events associated with dengue hemorrhagic fever and dengue shock syndrome.

22 e pathogenesis of the plasma leakage seen in dengue hemorrhagic fever and dengue shock syndrome.

23 f CLEC5A/MDL-1, a C-type lectin critical for dengue hemorrhagic fever and Japanese encephalitis virus

24 ses develop severe manifestations, including dengue hemorrhagic fever and shock syndrome, resulting i

25 elevant to understanding the pathogenesis of dengue hemorrhagic fever and the design of new vaccinati

26 ENV) is the causative agent of dengue fever, dengue hemorrhagic fever, and dengue shock syndrome and

27 spread human pathogens causing dengue fever, dengue hemorrhagic fever, and dengue shock syndrome, pla

28 a range of illness, including dengue fever, dengue hemorrhagic fever, and dengue shock syndrome.

29 Dengue fever and dengue hemorrhagic fever are significant global public h

30 increase the risk of severe outcomes, e.g., dengue hemorrhagic fever, dengue shock syndrome, and eve

31 e virus (DEN), which causes dengue fever and dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS)

32 e with hemorrhagic manifestations and shock (dengue hemorrhagic fever/dengue shock syndrome [DHF/DSS]

33 according to clinical dengue classification; dengue hemorrhagic fever/dengue shock syndrome severity;

34 (DEN), a flavivirus, causes dengue fever and dengue hemorrhagic fever/dengue shock syndrome, the most

35 Dengue virus (DEN) causes dengue fever and dengue hemorrhagic fever/dengue shock syndrome, which ar

36 anging from asymptomatic to life-threatening Dengue hemorrhagic fever/dengue shock syndrome.

37 irus (DENV) serotypes cause dengue fever and dengue hemorrhagic fever/dengue shock syndrome.

38 which is capable of causing dengue fever and dengue hemorrhagic fever/dengue shock syndrome.

39 umans, from dengue fever to the more serious dengue hemorrhagic fever/dengue shock syndrome.

40 gher at enrollment in patients who developed dengue hemorrhagic fever (DHF) (n = 11), compared with t

41 very cohort of patients with dengue fever or dengue hemorrhagic fever (DHF) (n = 166) and controls (n

42 l disease, and it can cause life-threatening dengue hemorrhagic fever (DHF) and dengue shock syndrome

43 that alter vascular fluid barrier functions, dengue hemorrhagic fever (DHF) and dengue shock syndrome

44 gue fever (DF) and its severe complications, dengue hemorrhagic fever (DHF) and dengue shock syndrome

45 Understanding the pathogenesis of dengue hemorrhagic fever (DHF) and dengue shock syndrome

46 ever, but, in severe cases, life-threatening dengue hemorrhagic fever (DHF) and dengue shock syndrome

47 The morbidity and mortality resulting from dengue hemorrhagic fever (DHF) are largely caused by end

48 ports have demonstrated immune activation in dengue hemorrhagic fever (DHF) by cytokine and soluble r

49 The mean age of dengue hemorrhagic fever (DHF) cases increased considera

50 rile illnesses (OFI), dengue fever (DF), and dengue hemorrhagic fever (DHF) cases.

51 to play a role in the immunopathogenesis of dengue hemorrhagic fever (DHF) during a secondary dengue

52 the HLA-B44 supertype was protective against dengue hemorrhagic fever (DHF) in secondary infections (

53 IgG) (RNNIg) is the greatest risk factor for dengue hemorrhagic fever (DHF) or dengue shock syndrome

54 es (DENV-1-4) that causes Dengue fever (DF), Dengue hemorrhagic Fever (DHF) or Dengue shock syndrome

55 ssociated with serious complications such as dengue hemorrhagic fever (DHF) or dengue shock syndrome

56 le few develop the life-threatening diseases dengue hemorrhagic fever (DHF) or dengue shock syndrome

57 e mechanisms leading to the life-threatening dengue hemorrhagic fever (DHF) remain elusive.

58 rile illness to classic dengue fever (DF) to dengue hemorrhagic fever (DHF), a potentially life-threa

59 ated febrile illness to dengue fever (DF) to dengue hemorrhagic fever (DHF), a potentially life-threa

60 dividuals infected with dengue virus develop dengue hemorrhagic fever (DHF), a viral hemorrhagic dise

61 sent a range of symptoms: dengue fever (DF), dengue hemorrhagic fever (DHF), and dengue shock syndrom

62 vere complication of dengue virus infection, dengue hemorrhagic fever (DHF), is hypothesized to be im

63 fever (DF) and its more severe presentation, dengue hemorrhagic fever (DHF), make it the most importa

64 secondary dengue virus (DENV) infections and dengue hemorrhagic fever (DHF), the majority of secondar

65 zed, and epidemiological evidence shows that dengue hemorrhagic fever (DHF), the more serious manifes

66 Dengue hemorrhagic fever (DHF), the most severe form of

67 Dengue hemorrhagic fever (DHF), the severe manifestation

68 In some patients with dengue hemorrhagic fever (DHF), vascular pathology can b

69 involved in the production of severe dengue, dengue hemorrhagic fever (DHF), versus the more common d

70 The more severe infections lead to dengue hemorrhagic fever (DHF), which can be life threat

71 he milder dengue fever to severe disease, or dengue hemorrhagic fever (DHF).

72 omarker distinguishing dengue fever (DF) and dengue hemorrhagic fever (DHF).

73 usively in humans, are dengue fever (DF) and dengue hemorrhagic fever (DHF).

74 ve agent of dengue fever and the more-severe dengue hemorrhagic fever (DHF).

75 econdary infection is a major risk factor in dengue hemorrhagic fever (DHF).

76 he role of virus load in the pathogenesis of dengue hemorrhagic fever (DHF).

77 spective studies of children presenting with dengue hemorrhagic fever (DHF).

78 Dengue virus infection can cause dengue hemorrhagic fever (DHF).

79 agents of dengue fever (DF) and more severe dengue hemorrhagic fever (DHF)/dengue shock syndrome, in

80 on presenting as dengue fever (DF; mild) and dengue hemorrhagic fever (DHF; severe) and subjects with

81 but was lowest in plasma from patients with dengue hemorrhagic fever due to secondary DV3 infection.

82 for the early diagnosis of dengue fever and dengue hemorrhagic fever during the acute viremic phase

83 howed that dengue serotype 2 viruses causing dengue hemorrhagic fever epidemics (Southeast Asian geno

84 ntial causes of the interepidemic periods in dengue hemorrhagic fever in Bangkok and of Plasmodium fa

85 evelop serious and possibly life-threatening dengue hemorrhagic fever in certain patients.

86 Dengue fever/dengue hemorrhagic fever is now one of the most importan

87 more severe form of dengue virus infection, dengue hemorrhagic fever, is characterized by plasma lea

88 Dengue hemorrhagic fever occurred in 24 (24.0%) of iverm

89 included hypersensitivity, dengue fever, and dengue hemorrhagic fever) occurred in the placebo group.

90 s, causes life-threatening diseases, such as dengue hemorrhagic fever or dengue shock syndrome.

91 anging from classical dengue fever to severe dengue hemorrhagic fever or dengue shock syndrome; howev

92 o more severe and sometimes life-threatening dengue hemorrhagic fever or shock, especially among chil

93 ited flu-like syndrome) and the emergence of dengue hemorrhagic fever (severe dengue with bleeding ab

94 e allocations that minimize the incidence of dengue hemorrhagic fever, taking into account limited av

95 Dengue hemorrhagic fever, the most severe form of dengue

96 Dengue hemorrhagic fever, the severe form of dengue viru

97 can facilitate the occurrence of more-severe dengue hemorrhagic fever through immune enhancement upon

98 Dengue hemorrhagic fever was defined according to 1997 W

99 The incidence of dengue hemorrhagic fever was less than 0.3 episodes per

100 arly 400 million people worldwide and causes dengue hemorrhagic fever, which is responsible for 10,00

101 an important human pathogen responsible for dengue hemorrhagic fever, whose global incidence has inc